UC Davis


UC Davis Health Ramps Up Project Lightspeed: Serves as Trial Site for Phase 2/3 BNT162 COVID-19 Vaccine Study

UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing of the COVID-19 vaccine candidate known as BTN162, developed by Germany’s BioNTech and Pfizer Inc. The addition of this pivotal clinical trial adds even a...

Record Number of UC Davis Spinoffs During Fiscal 2018 Year

Lisa Howard writing for University of California Davis reports a record number of new ventures during the fiscal 2018 year. Not counting the first half of fiscal 2019, UC Davis has enabled 137 start up ventures. The school reports that their startups target unmet...

Pin It on Pinterest